Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors

[1]  H. Wakimoto,et al.  Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity , 2023, Science Translational Medicine.

[2]  S. Andreadis,et al.  Well-Defined pH-Responsive Self-Assembled Block Copolymers for the Effective Codelivery of Doxorubicin and Antisense Oligonucleotide to Breast Cancer Cells. , 2022, ACS applied bio materials.

[3]  Y. Liu,et al.  Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy , 2022, Science Translational Medicine.

[4]  V. Truong,et al.  Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids , 2022, Translational oncology.

[5]  Y. S. Zhang,et al.  Micropore-Forming Gelatin Methacryloyl (GelMA) Bioink Toolbox 2.0: Designable Tunability and Adaptability for 3D Bioprinting Applications. , 2022, Small.

[6]  Ling Yang,et al.  [An injectable hydrogel/staple fiber composite for sustained release of CA4P and doxorubicin for combined chemotherapy of xenografted breast tumor in mice]. , 2022, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[7]  Jun-feng Ye,et al.  Hydrogel-based co-delivery of CIK cells and oncolytic adenovirus armed with IL12 and IL15 for cancer immunotherapy. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Jiasheng Tu,et al.  A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[9]  S. Barry,et al.  Injectable Diels-Alder cycloaddition hydrogels with tuneable gelation, stiffness and degradation for the sustained release of T-lymphocytes. , 2022, Journal of materials chemistry. B.

[10]  Quanyin Hu,et al.  Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy , 2022, Exploration.

[11]  Jianxun Ding,et al.  A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and Immunoactivation , 2022, Advanced materials.

[12]  Y. S. Zhang,et al.  Biosurfactant-Stabilized Micropore-Forming GelMA Inks Enable Improved Usability for 3D Printing Applications , 2022, Regenerative Engineering and Translational Medicine.

[13]  Y. S. Zhang,et al.  A multifunctional micropore-forming bioink with enhanced anti-bacterial and anti-inflammatory properties , 2022, Biofabrication.

[14]  J. Sun,et al.  Inhibition of Post-Surgery Tumour Recurrence via a Sprayable Chemoimmunotherapy Gel Releasing PD-L1 Antibody and Platelet-Derived Exosomes , 2021 .

[15]  Louai Labanieh,et al.  Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors , 2021, bioRxiv.

[16]  Jie Gao,et al.  Locally Injectable Hydrogels for Tumor Immunotherapy , 2021, Gels.

[17]  Chunmiao Xu,et al.  Personalized gel-droplet monocyte vaccines for cancer immunotherapy. , 2021, Lab on a Chip.

[18]  Y. S. Zhang,et al.  Digital Light Processing Based Bioprinting with Composable Gradients , 2021, Advanced materials.

[19]  Y. S. Zhang,et al.  High-resolution lithographic biofabrication of hydrogels with complex microchannels from low-temperature-soluble gelatin bioresins , 2021, Materials Today Bio.

[20]  P. Chu,et al.  Plasma-activated thermosensitive biogel as an exogenous ROS carrier for post-surgical treatment of cancer. , 2021, Biomaterials.

[21]  C. Chung,et al.  Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead , 2021, Journal for ImmunoTherapy of Cancer.

[22]  K. Shah,et al.  Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy? , 2021, Frontiers in Oncology.

[23]  G. Gurtner,et al.  Hydrogel Scaffolds to Deliver Cell Therapies for Wound Healing , 2021, Frontiers in Bioengineering and Biotechnology.

[24]  Quanyin Hu,et al.  Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets , 2021, Nature Biomedical Engineering.

[25]  P. Brastianos,et al.  Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers , 2021, Science Advances.

[26]  Y. Liu,et al.  Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection , 2021, Nature Nanotechnology.

[27]  Y. S. Zhang,et al.  Symbiotic Photosynthetic Oxygenation within 3D-Bioprinted Vascularized Tissues. , 2020, Matter.

[28]  J. Das,et al.  Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy , 2020, Frontiers in Chemistry.

[29]  Aileen W. Li,et al.  Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors , 2020, Nature Communications.

[30]  H. Cheung,et al.  Stem Cell-Based Therapies for Parkinson Disease , 2020, International journal of molecular sciences.

[31]  Y. S. Zhang,et al.  Bioprinted Injectable Hierarchically Porous Gelatin Methacryloyl Hydrogel Constructs with Shape‐Memory Properties , 2020, Advanced functional materials.

[32]  S. Maharjan,et al.  An open-source handheld extruder loaded with pore-forming bioink for in situ wound dressing , 2020, Materials today. Bio.

[33]  Ibrahim T. Ozbolat,et al.  Intraoperative Bioprinting: Repairing Tissues and Organs in a Surgical Setting. , 2020, Trends in biotechnology.

[34]  Ronnie H. Fang,et al.  Nanoparticle-hydrogel superstructures for biomedical applications. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[35]  M. Lenardo,et al.  A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.

[36]  S. Liang,et al.  A pH-responsive dissociable mesoporous silica-based nanoplatform enabling efficient dual-drug co-delivery and rapid clearance for cancer therapy. , 2020, Biomaterials science.

[37]  C. Fan,et al.  DNA-Edited Ligand Positioning on Red Blood Cells to Enable Optimized T Cell Activation for Adoptive Immunotherapy. , 2020, Angewandte Chemie.

[38]  F. Frascoli,et al.  Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells , 2020, Applied Sciences.

[39]  H. Abken,et al.  IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells , 2020, Cells.

[40]  Y. S. Zhang,et al.  Complexation-induced resolution enhancement of 3D-printed hydrogel constructs , 2020, Nature Communications.

[41]  A. Martín-Montalvo,et al.  Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy , 2020, Frontiers in Bioengineering and Biotechnology.

[42]  D. Irvine,et al.  Enhancing cancer immunotherapy with nanomedicine , 2020, Nature Reviews Immunology.

[43]  W. Miller,et al.  A review of cancer immunotherapy: from the past, to the present, to the future. , 2019, Current oncology.

[44]  Jinhui Wu,et al.  Hydrogel-based controlled drug delivery for cancer treatment: a review. , 2019, Molecular pharmaceutics.

[45]  C. Jin,et al.  Nano-Enhanced Drug Delivery and Therapeutic Ultrasound for Cancer Treatment and Beyond , 2019, Front. Bioeng. Biotechnol..

[46]  Thanh Loc Nguyen,et al.  Physically crosslinked injectable hydrogels for long-term delivery of oncolytic adenoviruses for cancer treatment. , 2019, Biomaterials science.

[47]  I. Melero,et al.  Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.

[48]  J. Nemunaitis,et al.  Natural killer cells: a Review of biology, therapeutic potential and challenges in treatment of solid tumors. , 2019, Future oncology.

[49]  N. Gu,et al.  Current applications and future prospects of nanotechnology in cancer immunotherapy , 2019, Cancer biology & medicine.

[50]  G. Schuler,et al.  Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance , 2019, Cancers.

[51]  D. Mooney,et al.  Macroscale biomaterials strategies for local immunomodulation , 2019, Nature Reviews Materials.

[52]  G. Sethi,et al.  Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs. , 2019, The international journal of biochemistry & cell biology.

[53]  G. Hutton,et al.  Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives , 2019, Biomedicines.

[54]  S. Endres,et al.  Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells , 2019, International journal of molecular sciences.

[55]  L. Tang,et al.  Surgery-free injectable macroscale biomaterials for local cancer immunotherapy. , 2019, Biomaterials science.

[56]  A. Shimabukuro-Vornhagen,et al.  B Cell-Based Cancer Immunotherapy , 2019, Transfusion Medicine and Hemotherapy.

[57]  Vladimir P. Torchilin,et al.  Hydrogels and Their Applications in Targeted Drug Delivery , 2019, Molecules.

[58]  Rachel S. Riley,et al.  Delivery technologies for cancer immunotherapy , 2019, Nature Reviews Drug Discovery.

[59]  D. Curiel,et al.  Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer , 2018, Molecular therapy oncolytics.

[60]  Quanyin Hu,et al.  In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment , 2018, Nature Nanotechnology.

[61]  C. Figdor,et al.  Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery , 2018, Front. Immunol..

[62]  Hong Wang,et al.  Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. , 2017, Cytotherapy.

[63]  K. Shah,et al.  Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas , 2017, Clinical Cancer Research.

[64]  Y. S. Zhang,et al.  Structural analysis of photocrosslinkable methacryloyl-modified protein derivatives. , 2017, Biomaterials.

[65]  H. Wakimoto,et al.  Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas , 2017, Proceedings of the National Academy of Sciences.

[66]  K. Shah,et al.  Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors , 2017, Scientific Reports.

[67]  N. Taylor,et al.  CAR T‐cell therapy of solid tumors , 2017, Immunology and cell biology.

[68]  Zhongyan Wang,et al.  A Powerful CD8+ T‐Cell Stimulating D‐Tetra‐Peptide Hydrogel as a Very Promising Vaccine Adjuvant , 2017, Advanced materials.

[69]  Ali Khademhosseini,et al.  Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms , 2016, Nature Protocols.

[70]  P. Lollini,et al.  Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases , 2015, Oncotarget.

[71]  A. Salgado,et al.  Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration , 2015, Stem cells international.

[72]  D. van der Kooy,et al.  A Hyaluronan-Based Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following Transplantation , 2015, Stem cell reports.

[73]  S. B. Stephan,et al.  Biopolymer implants enhance the efficacy of adoptive T cell therapy , 2014, Nature Biotechnology.

[74]  Yaron Mazor,et al.  Cell-based therapy approaches: the hope for incurable diseases. , 2014, Regenerative medicine.

[75]  H. Wakimoto,et al.  Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. , 2014, Journal of the National Cancer Institute.

[76]  Jonathan D. Suever,et al.  Cellular Encapsulation Enhances Cardiac Repair , 2013, Journal of the American Heart Association.

[77]  K. Shah.  Encapsulated stem cells for cancer therapy , 2013, Biomatter.

[78]  K. Shah,et al.  Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas , 2011, Nature Neuroscience.

[79]  V. Altanerová,et al.  Stem cell based cancer gene therapy. , 2011, Molecular pharmaceutics.

[80]  W. Hennink,et al.  In situ gelling hydrogels for pharmaceutical and biomedical applications. , 2008, International journal of pharmaceutics.

[81]  D. García-Olmo,et al.  Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy , 2003, International Journal of Colorectal Disease.

[82]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.